A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys is a research paper published in Psychopharmacology (2025). On theSindex it has a DataRank of 0.356. It has been cited 9 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0110
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
National Institute on Drug Abuse
Grant: U01DA51658
National Institute on Drug Abuse
Grant: UG3DA057850
National Institute on Drug Abuse
Grant: T32DA031115
Welch Foundation
Grant: AQ-0039
NIDA NIH HHS
Grant: U01 DA051658
National Institutes of Health
Grant: 1T32DA031115-01
Training in Drug Abuse Research: Behavior and Neurobiology
National Institutes of Health
Grant: 1UG3DA057850-01
Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials
National Institutes of Health
Grant: 7U01DA051658-03
Antibody-based countermeasures against fentanyl and its analogues
Fields of Study
MeSH Terms
Keywords